Market Access Europe at eyeforpharma Barcelona
March 12 - 14, 2019 - Barcelona UKeyeforpharma
jmackintosh@eyeforpharma.com
Phone:+4402073757163
Key Themes Explored in 2019 Build the market access ecosystem: Foster genuine payment innovation with stakeholder collaboration to match rapidly increasing treatment effectiveness Access at Day 1: Make market access a company-wide imperative, from the start of development through commercialisation Translate patient to payer value: Find KPIs which justify pricing models through measuring real patient journeys Big data, bigger opportunity: Ensure real-world evidence meets payer standards to guarantee decision-making impact The event will be driven by pharma senior executives and key stakeholders across the industry, including: • Martin Price, VP, HEOR, Market Access and Reimbursement, Janssen • Daniel Jackson, Global Head, Market Access Solutions and Strategy, UCB • Gillian Leng, Deputy Chief Executive Officer, NICE • Giuseppe Rosano, Member CVWP, European Medicines Agency, Consultant Cardiologist, Agenzia Italiana del Farmaco • Ruediger Papsch, Senior Director, Global Head Market Access and Pricing Fertility, Merck KGaA